Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

23 mars 2010 08h32 HE | Source: Pluri Inc.

Pluristem Therapeutics Granted European Union Patent for PluriX(TM) Three-Dimensional (3D) Bioreactor System

HAIFA, Israel, March 23, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has been granted a European Patent on its core 3D cell expansion...
09 mars 2010 08h00 HE | Source: Pluri Inc.

Pluristem to Present at the ROTH 22nd Annual OC Growth Conference

HAIFA, Israel, March 9, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced its participation in the Roth 22nd Annual OC Growth Conference to be held at The...
02 mars 2010 08h00 HE | Source: Pluri Inc.

Pluristem Therapeutics Receives DSMB Approval to Advance to Final Dose Level With PLX-PAD

HAIFA, Israel, March 2, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has received approval from an independent Data Safety Monitoring Board...
01 déc. 2009 08h00 HE | Source: Pluri Inc.

Pluristem Therapeutics Completes Dosing of First Group of Patients in Europe With Placenta-Derived Cell Therapy Product PLX-PAD in Phase I Clinical Trial for Treatment of Critical Limb Ischemia (CLI)

HAIFA, Israel, Dec. 1, 2009 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has completed dosing of the first of three dosage groups of patients in...
01 oct. 2009 18h45 HE | Source: Pluri Inc.

Pluristem Provides Disclosure Pursuant to NASDAQ Marketplace Rule 5250(b)(2)

HAIFA, Israel, Oct. 1, 2009 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced, that on September 23, 2009, it filed its Annual Report on Form 10-K with the SEC,...